• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

NQO2 Gene Record

  • Summary
  • Interactions
  • Claims
  • NQO2 4835 Druggable Genome

    Alternate Names:

    4835
    N-RIBOSYLDIHYDRONICOTINAMIDE:QUINONE REDUCTASE 2
    NQO2
    DHQV
    DIA6
    NMOR2
    QR2
    160998
    7856
    ENSG00000124588
    OTTHUMG00000014130
    P16083
    NQO2_HUMAN
    PA31745
    Quinone reductase 2
    T75498
    Ribosyldihydronicotinamide dehydrogenase [quinone]

    Gene Info:

    Target Main Class Enzymes
    Target Subclass 1.10.99.2
    Target Class Enzymes
    Target Subclass EC:1.10.99.2
    Gene Biotype PROTEIN_CODING
    (4 More Sources)

    Gene Categories: Category Details

    DRUGGABLE GENOME
    ENZYME

    Publications:

    Nolan KA et al., 2010, In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2)., Bioorg Med Chem Lett
    Radogna et al., 2009, Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes., Toxicol. Appl. Pharmacol.
    Michaelis S et al., 2012, Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)., J Med Chem
    Kwiek et al., 2004, Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines., Biochemistry
    Celli et al., 2006, NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs., Biochem. Pharmacol.
    Boutin et al., 2005, Quinone reductase 2 substrate specificity and inhibition pharmacology., Chem. Biol. Interact.
    Foster et al., 1999, Crystal structure of human quinone reductase type 2, a metalloflavoprotein., Biochemistry
    Long et al., 2002, Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity., J. Biol. Chem.
    Kalra S et al., 2018, Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening array., Eur J Clin Pharmacol
    Jamieson D et al., 2011, Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy., Pharmacogenet Genomics
  • CARICOTAMIDE   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name CB1954/EP-0152R, NQO2 prodrug therapy,Prolarix
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • CHEMBL1287895   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • CHEMBL1288281   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • CHEMBL1287866   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • CHEMBL1288253   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • CHEMBL1287867   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • CHEMBL476968   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • CHEMBL1983317   NQO2

    Interaction Score: 4.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21074425


    Sources:
    DTC

  • DABIGATRAN   NQO2

    Interaction Score: 0.92

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22494098


    Sources:
    DTC

  • MENADIONE   NQO2

    Interaction Score: 0.88

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15078100 16765324 15733542 10433694 12351651


    Sources:
    TEND

  • C-1311   NQO2

    Interaction Score: 0.82

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • MELATONIN   NQO2

    Interaction Score: 0.32

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    19463840


    Sources:
    TTD

  • CYCLOPHOSPHAMIDE   NQO2

    Interaction Score: 0.16

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    29938344 21946896


    Sources:
    PharmGKB

  • DOXORUBICIN   NQO2

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    29938344 21946896


    Sources:
    PharmGKB

  • IMATINIB   NQO2

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22494098


    Sources:
    DTC

  • Ensembl: ENSG00000124588

    • Version: 101_38

    Alternate Names:
    NQO2 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • TEND: P16083

    • Version: 01-August-2011

    Alternate Names:
    ENSG00000124588 Ensembl Gene Id
    P16083 Uniprot Accession
    NQO2_HUMAN Uniprot Id

    Gene Info:
    Target Main Class Enzymes
    Target Subclass 1.10.99.2

    Publications:

  • TdgClinicalTrial: P16083

    • Version: January-2014

    Alternate Names:
    NQO2 Gene Symbol

    Gene Info:
    Target Class Enzymes
    Target Subclass EC:1.10.99.2

    Publications:

  • PharmGKB: NQO2

    • Version: 18-August-2020

    Alternate Names:
    PA31745 PharmGKB ID

    Gene Info:

    Publications:
    Kalra S et al., 2018, Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening array., Eur J Clin Pharmacol
    Jamieson D et al., 2011, Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy., Pharmacogenet Genomics

  • DTC: NQO2

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Nolan KA et al., 2010, In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2)., Bioorg Med Chem Lett
    Michaelis S et al., 2012, Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)., J Med Chem

  • HingoraniCasas: ENSG00000124588

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000124588 Gene Symbol
    NQO2 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • TTD: Quinone reductase 2

    • Version: 2020.06.01

    Alternate Names:
    NQO2 TTD Gene Abbreviation
    T75498 TTD Target ID

    Gene Info:

    Publications:

  • Pharos: NQO2

    • Version: 01-February-2022

    Alternate Names:
    Ribosyldihydronicotinamide dehydrogenase [quinone] Gene Name
    P16083 UniProt ID

    Gene Info:

    Gene Categories:
    ENZYME

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21